198 related articles for article (PubMed ID: 29923174)
1. Circulating tumor DNA analysis enables molecular characterization of pediatric renal tumors at diagnosis.
Jiménez I; Chicard M; Colmet-Daage L; Clément N; Danzon A; Lapouble E; Pierron G; Bohec M; Baulande S; Berrebi D; Fréneaux P; Coulomb A; Galmiche-Rolland L; Sarnacki S; Audry G; Philippe-Chomette P; Brisse HJ; Doz F; Michon J; Delattre O; Schleiermacher G
Int J Cancer; 2019 Jan; 144(1):68-79. PubMed ID: 29923174
[TBL] [Abstract][Full Text] [Related]
2. Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study.
Chagtai T; Zill C; Dainese L; Wegert J; Savola S; Popov S; Mifsud W; Vujanić G; Sebire N; Le Bouc Y; Ambros PF; Kager L; O'Sullivan MJ; Blaise A; Bergeron C; Mengelbier LH; Gisselsson D; Kool M; Tytgat GA; van den Heuvel-Eibrink MM; Graf N; van Tinteren H; Coulomb A; Gessler M; Williams RD; Pritchard-Jones K
J Clin Oncol; 2016 Sep; 34(26):3195-203. PubMed ID: 27432915
[TBL] [Abstract][Full Text] [Related]
3. Preoperative diagnosis of clear cell sarcoma of the kidney by detection of BCOR internal tandem duplication in circulating tumor DNA.
Ueno-Yokohata H; Okita H; Nakasato K; Hishiki T; Shirai R; Tsujimoto S; Osumi T; Yoshimura S; Yamada Y; Shioda Y; Kiyotani C; Terashima K; Miyazaki O; Matsumoto K; Kiyokawa N; Yoshioka T; Kato M
Genes Chromosomes Cancer; 2018 Oct; 57(10):525-529. PubMed ID: 30126017
[TBL] [Abstract][Full Text] [Related]
4. Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533.
Madanat-Harjuoja LM; Renfro LA; Klega K; Tornwall B; Thorner AR; Nag A; Dix D; Dome JS; Diller LR; Fernandez CV; Mullen EA; Crompton BD
J Clin Oncol; 2022 Sep; 40(26):3047-3056. PubMed ID: 35580298
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.
Smith CG; Moser T; Mouliere F; Field-Rayner J; Eldridge M; Riediger AL; Chandrananda D; Heider K; Wan JCM; Warren AY; Morris J; Hudecova I; Cooper WN; Mitchell TJ; Gale D; Ruiz-Valdepenas A; Klatte T; Ursprung S; Sala E; Riddick ACP; Aho TF; Armitage JN; Perakis S; Pichler M; Seles M; Wcislo G; Welsh SJ; Matakidou A; Eisen T; Massie CE; Rosenfeld N; Heitzer E; Stewart GD
Genome Med; 2020 Feb; 12(1):23. PubMed ID: 32111235
[TBL] [Abstract][Full Text] [Related]
6. Plasma Circulating Tumor DNA and Clonal Hematopoiesis in Metastatic Renal Cell Carcinoma.
Bacon JVW; Annala M; Soleimani M; Lavoie JM; So A; Gleave ME; Fazli L; Wang G; Chi KN; Kollmannsberger CK; Wyatt AW; Nappi L
Clin Genitourin Cancer; 2020 Aug; 18(4):322-331.e2. PubMed ID: 32046920
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Renal Function in Pediatric Patients After Treatment for Wilms' Tumor.
Janeczko M; Niedzielska E; Pietras W
Adv Clin Exp Med; 2015; 24(3):497-504. PubMed ID: 26467140
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancer.
Guan X; Liu B; Niu Y; Dong X; Zhu X; Li C; Li L; Yi Z; Sun X; Chen H; Lu S; Ma F
Breast; 2020 Feb; 49():261-266. PubMed ID: 31927339
[TBL] [Abstract][Full Text] [Related]
9. A Comprehensive Circulating Tumor DNA Assay for Detection of Translocation and Copy-Number Changes in Pediatric Sarcomas.
Shah AT; Azad TD; Breese MR; Chabon JJ; Hamilton EG; Straessler K; Kurtz DM; Leung SG; Spillinger A; Liu HY; Behroozfard IH; Wittber FM; Hazard FK; Cho SJ; Daldrup-Link HE; Vo KT; Rangaswami A; Pribnow A; Spunt SL; Lacayo NJ; Diehn M; Alizadeh AA; Sweet-Cordero EA
Mol Cancer Ther; 2021 Oct; 20(10):2016-2025. PubMed ID: 34353895
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of blastemal predominant histology in initially resected Wilms' tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan.
Kinoshita Y; Suminoe A; Inada H; Yagi M; Yanai F; Zaizen Y; Nishi M; Inomata Y; Kawakami K; Matsufuji H; Suenobu S; Handa N; Kohashi K; Oda Y; Hara T; Taguchi T
J Pediatr Surg; 2012 Dec; 47(12):2205-9. PubMed ID: 23217877
[TBL] [Abstract][Full Text] [Related]
11. Imaging accuracy and incidence of Wilms' and non-Wilms' renal tumors in children.
Miniati D; Gay AN; Parks KV; Naik-Mathuria BJ; Hicks J; Nuchtern JG; Cass DL; Olutoye OO
J Pediatr Surg; 2008 Jul; 43(7):1301-7. PubMed ID: 18639686
[TBL] [Abstract][Full Text] [Related]
12. Immune expression in children with Wilms tumor: a pilot study.
Holl EK; Routh JC; Johnston AW; Frazier V; Rice HE; Tracy ET; Nair SK
J Pediatr Urol; 2019 Oct; 15(5):441.e1-441.e8. PubMed ID: 30981637
[TBL] [Abstract][Full Text] [Related]
13. The role of TCF3 as potential master regulator in blastemal Wilms tumors.
Kehl T; Schneider L; Kattler K; Stöckel D; Wegert J; Gerstner N; Ludwig N; Distler U; Tenzer S; Gessler M; Walter J; Keller A; Graf N; Meese E; Lenhof HP
Int J Cancer; 2019 Mar; 144(6):1432-1443. PubMed ID: 30155889
[TBL] [Abstract][Full Text] [Related]
14. Management of Wilms tumor: current standard of care.
Sonn G; Shortliffe LM
Nat Clin Pract Urol; 2008 Oct; 5(10):551-60. PubMed ID: 18836464
[TBL] [Abstract][Full Text] [Related]
15. Indications and results of diagnostic biopsy in pediatric renal tumors: A retrospective analysis of 317 patients with critical review of SIOP guidelines.
de la Monneraye Y; Michon J; Pacquement H; Aerts I; Orbach D; Doz F; Bourdeaut F; Sarnacki S; Philippe-Chomette P; Audry G; Coulomb A; Fréneaux P; Klijanienko J; Berrebi D; Zucker JM; Schleiermacher G; Brisse HJ
Pediatr Blood Cancer; 2019 Jun; 66(6):e27641. PubMed ID: 30746839
[TBL] [Abstract][Full Text] [Related]
16. Genomewide copy number alteration screening of circulating plasma DNA: potential for the detection of incipient tumors.
Lenaerts L; Vandenberghe P; Brison N; Che H; Neofytou M; Verheecke M; Leemans L; Maggen C; Dewaele B; Dehaspe L; Vanderschueren S; Dierickx D; Vandecaveye V; Amant F; Vermeesch JR
Ann Oncol; 2019 Jan; 30(1):85-95. PubMed ID: 30371735
[TBL] [Abstract][Full Text] [Related]
17. Tumor-specific genetic aberrations in cell-free DNA of gastroesophageal cancer patients.
Koldby KM; Mortensen MB; Detlefsen S; Pfeiffer P; Thomassen M; Kruse TA
J Gastroenterol; 2019 Feb; 54(2):108-121. PubMed ID: 30242476
[TBL] [Abstract][Full Text] [Related]
18. Correlation of genomic alterations between tumor tissue and circulating tumor DNA by next-generation sequencing.
Chang YS; Fang HY; Hung YC; Ke TW; Chang CM; Liu TY; Chen YC; Chao DS; Huang HY; Chang JG
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2167-2175. PubMed ID: 30203147
[TBL] [Abstract][Full Text] [Related]
19. The role of biopsy in the diagnosis of renal tumors of childhood: Results of the UKCCSG Wilms tumor study 3.
Vujanić GM; Kelsey A; Mitchell C; Shannon RS; Gornall P
Med Pediatr Oncol; 2003 Jan; 40(1):18-22. PubMed ID: 12426681
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of Wilms' tumour-1 protein (WT-1) immunostaining in paediatric renal tumours.
Goyal S; Mishra K; Sarkar U; Sharma S; Kumari A
Indian J Med Res; 2016 May; 143(Supplement):S59-S67. PubMed ID: 27748279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
